These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30236398)

  • 21. Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: Results of the Adaptive Cardiac Resynchronization Therapy Trial.
    Birnie D; Hudnall H; Lemke B; Aonuma K; Lee KL; Gasparini M; Gorcsan J; Cerkvenik J; Martin DO
    Heart Rhythm; 2017 Dec; 14(12):1820-1825. PubMed ID: 28893549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.
    Ferreira AM; Adragão P; Cavaco DM; Candeias R; Morgado FB; Santos KR; Santos E; Silva JA
    Europace; 2008 Jul; 10(7):809-15. PubMed ID: 18511438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel algorithm increases the delivery of effective cardiac resynchronization therapy during atrial fibrillation: The CRTee randomized crossover trial.
    Plummer CJ; Frank CM; Bári Z; Al Hebaishi YS; Klepfer RN; Stadler RW; Ghosh S; Liu S; Mittal S
    Heart Rhythm; 2018 Mar; 15(3):369-375. PubMed ID: 29132930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial Fibrillation During Cardiac Resynchronization Therapy.
    Kloosterman M; Maass AH; Rienstra M; Van Gelder IC
    Card Electrophysiol Clin; 2015 Dec; 7(4):735-48. PubMed ID: 26596815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time.
    Buck S; Rienstra M; Maass AH; Nieuwland W; Van Veldhuisen DJ; Van Gelder IC
    Europace; 2008 May; 10(5):558-65. PubMed ID: 18356205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency and Outcomes of Postrandomization Atrial Tachyarrhythmias in the Resynchronization/Defibrillation in Ambulatory Heart Failure Trial.
    Wilton SB; Exner DV; Wyse DG; Yetisir E; Wells G; Tang AS; Healey JS
    Circ Arrhythm Electrophysiol; 2016 May; 9(5):. PubMed ID: 27162033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation.
    Gasparini M; Auricchio A; Metra M; Regoli F; Fantoni C; Lamp B; Curnis A; Vogt J; Klersy C;
    Eur Heart J; 2008 Jul; 29(13):1644-52. PubMed ID: 18390869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive impact of pulmonary vein isolation on biventricular pacing in nonresponders to cardiac resynchronization therapy.
    Fink T; Rexha E; Schlüter M; Lemes C; Maurer T; Heeger CH; Reissmann B; Rottner L; Tönnis T; Ujeyl A; Krüger M; Portz N; Wohlmuth P; Mathew S; Ouyang F; Rillig A; Kuck KH; Metzner A
    Heart Rhythm; 2019 Mar; 16(3):416-423. PubMed ID: 30273766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy.
    Mittal S; Musat DL; Hoskins MH; Prillinger JB; Roberts GJ; Nabutovsky Y; Merchant FM
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29180458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probability of sinus rhythm conversion and maintenance in cardiac resynchronization therapy patients with atrial fibrillation during 5-year follow-up.
    Ziegelhoeffer T; Pecha S; Rahmani R; Thaqi N; Ackermann X; Hakmi S; Choi YH; Burger H
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2393-2402. PubMed ID: 32652754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
    Saksena S; Slee A; Saad M
    J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial Fibrillation During Cardiac Resynchronization Therapy.
    Kloosterman M; Maass AH; Rienstra M; Van Gelder IC
    Heart Fail Clin; 2017 Jan; 13(1):179-192. PubMed ID: 27886922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Causes of non-response to cardiac resynchronization therapy in heart failure patients with permanent atrial fibrillation].
    Wang DM; Yu HB; Qi SY; Ding C; Wang G; Han YL; Zang HY; Ru LS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Sep; 40(9):757-61. PubMed ID: 23141088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
    Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of chronic atrial fibrillation in patients with severe heart failure and indication for CRT: data of two registries with 711 patients (1999-2006 and 2007-6/2008).
    Luedorff G; Grove R; Kowalski M; Wolff E; Thale J; Kranig W
    Herzschrittmacherther Elektrophysiol; 2011 Dec; 22(4):226-32. PubMed ID: 22160274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study).
    Tolosana JM; Hernandez Madrid A; Brugada J; Sitges M; Garcia Bolao I; Fernandez Lozano I; Martinez Ferrer J; Quesada A; Macias A; Marin W; Escudier JM; Gomez AA; Gimenez Alcala M; Tamborero D; Berruezo A; Mont L;
    Am J Cardiol; 2008 Aug; 102(4):444-9. PubMed ID: 18678303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Post hoc analysis on rhythm and high intensity interval training in cardiac resynchronization therapy.
    Melo X; Abreu A; Santos V; Cunha P; Oliveira M; Pinto R; Carmo M; Fernhall B; Santa-Clara H
    Scand Cardiovasc J; 2019 Aug; 53(4):197-205. PubMed ID: 31221002
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of new-generation atrial antitachycardia pacing for atrial tachyarrhythmias in patients implanted with cardiac resynchronization therapy devices.
    Ueda N; Kamakura T; Noda T; Nakajima K; Kataoka N; Wada M; Yamagata K; Ishibashi K; Inoue Y; Miyamoto K; Nagase S; Aiba T; Izumi C; Noguchi T; Yasuda S; Kusano K
    J Cardiol; 2020 May; 75(5):559-566. PubMed ID: 31672258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac resynchronization therapy in patients with atrial fibrillation: a meta-analysis.
    Lopes C; Pereira T; Barra S
    Rev Port Cardiol; 2014 Nov; 33(11):717-25. PubMed ID: 25457476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.